References
- Frick M H., Elo O, Haapa K, et al. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237–45
- Manninen V, Elo O, Frlck M H., et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988; 260: 641–51
- Mänttäri M, Elo O, Frick M H., et al. Helsinki Heart Study: Basic design and randomization procedure. Eur Heart J 1987; 8(Suppl. 1)1–29
- Friedewald W T., Van den Fredrickson D S. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultrasentrifuge. Clin Chem 1972; 18: 499–502
- Rossouw J E., Lewis B, Rifkind B M. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990; 323: 1112–9
- Carlson L A., Rosenhamer G. Reduction of mortality in the Stockholm Ishaemic Heart Disease Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand 1988; 223: 405–18
- Canner P L., Berge K G., Wegner N K., et al. Fifteen-year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8: 1245–55
- Nikkilä E A., Vilkinkosi P, Valle M, Frick M H. Prevention of progression of coronary atherosclerosis by treatment of dyslipidemia. A seven year prospective angiographic study. Br Med J 1984; 289: 220–3
- Arntzenius A C., Kromhout D, Barth J D., et al. Diet, lipoproteins and the progression of coronary atherosclerosis. N Engl J Med 1985; 313: 805–11
- Blankenhorn D H., Nessim S A., Johnson R L., Sanmarco M E., Azen S P., Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous grafts. JAMA 1987; 257: 3233–42
- Brown G, Albers J J., Fischer L D., et al. Regression of coronary artery disease as a result of intensive lipidlowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289–98
- Humphries J O., Kuller L, Ross R S., Friesinger G C., Page E E. Natural history of ischaemic heart disease in relation to arteriographic findings. Circulation 1974; 49: 489–97
- Hammermeister K E., DeRouen T A., Dodge H T. Variables predictive of survival in patients with coronary disease: prediction by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic and quantitative angiographic evaluations. Circulation 1979; 59: 421–30
- Detre K, Kuller L H. Hazards in the evaluation of secondary prevention trials. Am J Epidemiol 1979; 109: 400–4
- Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 1992; 85: 37–45